Primaquine analogues that are potent anti-Trypanosoma cruzi: Agents in a mouse model

Annals of Tropical Medicine and Parasitology

Volumn 90, Issue 5, 1996, Pages 467-474

  Kinnamon, K E ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ANTITRYPANOSOMAL AGENT; NIFURTIMOX; PRIMAQUINE; PRIMAQUINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHELMINTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARASITEMIA; TRYPANOSOMA CRUZI;

ANIMALIA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0029907471     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1080/00034983.1996.11813071     Document Type: Article

References (3)

1. BRENER, Z. (1979). Present status of chemotherapy and chemoprophylaxis of human trypanosomiasis in the western hemisphere. Pharmacology and Therapeutics, 7, 71-90.
2. DOVRAK, J. A., HARTMAN, D. L. & MILES, M. A. (1980). Trypanosoma cruzi: correlation of growth kinetic zymodeme type in clones derived from various sources. American Journal of Tropical Medicine and Hygiene, 47, 472-474.
3. GOBLE, F. C. (1949). Chemotherapeutic activity of certain 8-aminoquinolines, particularly pentaquine in experimental Chagas' disease. Journal of Parasitology, 35, 375-378.